FRMD8 and breast carcinoma: ATG2A exhibits mutations in breast cancer, FRMD8 plays a tumor-suppressive role in breast cancer progression, ARSG is negatively correlated with positive prognosis, and differentially expressed genes upregulated by SAC3D1 are involved in regulating the cell cycle pathways in breast cancer cells.